Korea Expands National Medical Insurance Coverage Of Tamiflu, Relenza To Fight Swine Flu

SEOUL - With global health authorities warning of the possibility of the swine flu blooming into a pandemic, Korea's Ministry for Health, Welfare and Family Affairs has begun to cover Roche's Tamiflu (oseltamivir) and GlaxoSmithKline's Relenza (zanamivir) under the National Medical Insurance System for those likely exposed to the swine flu